Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
Saved in:
| Title: | Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. |
|---|---|
| Authors: | Pathak DS; Center for Health Outcomes, Policy, and Evaluation Studies, College of Medicine and Public Health, The Ohio State University, Columbus 43210-1234, USA., Davis EA, Stanford RH |
| Source: | Pharmacotherapy [Pharmacotherapy] 2002 Feb; Vol. 22 (2), pp. 166-74. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print Cited Medium: Print ISSN: 0277-0008 (Print) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
